Importância da triagem pré-natal no manejo da sífilis gestacional e impactos para o concepto: uma revisão integrativa

A gestante diagnosticada com sífilis que não é tratada ou que é tratada de forma inadequada, pode transmitir essa infecção ao concepto, causando a sífilis congênita, um problema global de saúde pública, principalmente, em países em desenvolvimento, como o Brasil. Dentre os fatores que estão associados aos elevados números de sífilis congênita, pode-se destacar a falta ou uma assistência pré-natal deficiente. A presente revisão integrativa objetivou discutir a importância da assistência pré-natal de qualidade no manejo de grávidas com sífilis e seu impacto para a saúde concepto. Entre agosto e outubro de 2023, foi realizado o levantamento bibliográfico utilizando os descritores “sífilis” (syphilis), “cuidado pré-natal” (prenatal care) e “parto” (parturition) e seguindo os seguintes critérios de inclusão: artigos publicados nos últimos cinco anos, escritos em português ou inglês, publicados em periódicos com classificação Qualis CAPES mínimo B2 e com texto completo eletronicamente disponível. Após a busca bibliográfica, foram identificados um total de 111 artigos, sendo 90 na BVS e 11 na PubMed. Destes, 9 atenderam a todos os critérios e foram incluídos na presente revisão. Percebe-se que a falta de acesso ou o manejo deficiente da gestante com sífilis (diagnóstico tardio ou tratamento inadequado) durante a assistência pré-natal é responsável pelos números elevados de casos de sífilis congênita. Assim, faz-se necessário o desenvolvimento de estratégias que busquem fortalecer e qualificar a assistência pré-natal às gestantes com sífilis para reduzir ou eliminar os casos de sífilis congênita

Divulgação científica e o projeto momento ciência

O projeto Momento Ciência tem como propósito tornar o conhecimento cientifico acessível, promovendo a divulgação científica através do contato direto de alunos de ensino médio de escolas públicas do Distrito Federal e alunos recém aprovados, calouros, nos cursos de Ciências Biológicas e de Biotecnologia na Universidade de Brasília (UnB). Esse contato com a comunidade científica ocorre por meio de visitas aos laboratórios acadêmicos do Instituto de Ciências Biológicas (IB) da Universidade de Brasília. O projeto obteve resultados positivos e esperados ao longo da sua execução

Sepse: avaliação da qualidade do atendimento em setor de urgência e emergência: Sepsis: assessment of the quality of emergency and emergency care

A Sepse corresponde à presença de uma disfunção orgânica fatal provocada por uma resposta anormal do hospedeiro a um processo infeccioso, que pode progredir para um choque séptico. No decorrer dessa pesquisa, cuja metodologia foi a revisão integrativa de literatura, foram utilizados artigos científicos publicados em periódicos nacionais entre os anos de 2015 e 2022, retirados da base de dados Medline e Lilacs, sendo buscados a partir dos descritores: “Sepse”, “Qualidade do atendimento” e “Urgência e Emergência”. Com o objetivo de analisar a efetividade das ações de cuidados de Enfermagem aplicadas ao sepse adulto, a partir da análise de dados reunidos nesta revisão integrativa, foi possível concluir que a implantação de protocolos para o tratamento resultou em melhorias significativas nos indicadores de qualidade nos cuidados com a sepse, a exemplo da melhoria do fluxo e de atenção aos pacientes e redução da mortalidade nos setores de urgência e emergência

Patologias atuais: a compulsão e a sociedade dos excessos: Current pathologies: compulsion and the society of excesses

O artigo em tela tem por objetivo analisar os aspectos biopsicossociais da conduta compulsiva de consumo. Propõe-se a apresentar os elementos psicológicos contidos nesse comportamento, além de verificar quais são os resultados decorrentes dessa compulsão. O consumo compulsivo, também chamado de oniomania, é um transtorno causado pela ansiedade despertada pela necessidade de comprar e saciada, somente, quando é materializada a aquisição daquilo que se deseja comprar. O estudo em questão pode ser classificado como sendo de cunho bibliográfico, a partir da análise de documentos publicados em forma de artigos científicos e livros em formato digital

Dependência psicológica de Benzodiazepínicos: Psychological dependence on Benzodiazepines

O crescente aumento do seu uso no começo do século XXI, os ansiolíticos vêm se tornando a “porta de fuga” para nova e também velha geração. Geração essa, que cada vez mais vem sendo consumida por distúrbios de ansiedade, insônia e quadros depressivos de forma exponencial. (Faculdade de Ciências Farmacêuticas de Ribeirão Preto – 2019). Este trabalho, avalia o uso e possível dependência psicológica dos benzodiazepínicos, a partir de um levantamento bibliográfico de forma sistemática de pesquisas dentro da literatura científica acerca do assunto.&nbsp

Divulgação científica e o projeto momento ciência

O projeto Momento Ciência tem como propósito tornar o conhecimento cientifico acessível, promovendo a divulgação científica através do contato direto de alunos de ensino médio de escolas públicas do Distrito Federal e alunos recém aprovados, calouros, nos cursos de Ciências Biológicas e de Biotecnologia na Universidade de Brasília (UnB). Esse contato com a comunidade científica ocorre por meio de visitas aos laboratórios acadêmicos do Instituto de Ciências Biológicas (IB) da Universidade de Brasília. O projeto obteve resultados positivos e esperados ao longo da sua execução

NEOTROPICAL CARNIVORES: a data set on carnivore distribution in the Neotropics

Mammalian carnivores are considered a key group in maintaining ecological health and can indicate potential ecological integrity in landscapes where they occur. Carnivores also hold high conservation value and their habitat requirements can guide management and conservation plans. The order Carnivora has 84 species from 8 families in the Neotropical region: Canidae; Felidae; Mephitidae; Mustelidae; Otariidae; Phocidae; Procyonidae; and Ursidae. Herein, we include published and unpublished data on native terrestrial Neotropical carnivores (Canidae; Felidae; Mephitidae; Mustelidae; Procyonidae; and Ursidae). NEOTROPICAL CARNIVORES is a publicly available data set that includes 99,605 data entries from 35,511 unique georeferenced coordinates. Detection/non-detection and quantitative data were obtained from 1818 to 2018 by researchers, governmental agencies, non-governmental organizations, and private consultants. Data were collected using several methods including camera trapping, museum collections, roadkill, line transect, and opportunistic records. Literature (peer-reviewed and grey literature) from Portuguese, Spanish and English were incorporated in this compilation. Most of the data set consists of detection data entries (n = 79,343; 79.7%) but also includes non-detection data (n = 20,262; 20.3%). Of those, 43.3% also include count data (n = 43,151). The information available in NEOTROPICAL CARNIVORES will contribute to macroecological, ecological, and conservation questions in multiple spatio-temporal perspectives. As carnivores play key roles in trophic interactions, a better understanding of their distribution and habitat requirements are essential to establish conservation management plans and safeguard the future ecological health of Neotropical ecosystems. Our data paper, combined with other large-scale data sets, has great potential to clarify species distribution and related ecological processes within the Neotropics. There are no copyright restrictions and no restriction for using data from this data paper, as long as the data paper is cited as the source of the information used. We also request that users inform us of how they intend to use the data

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

© 2020 Elsevier Ltd. All rights reserved.Background: Hereditary transthyretin-mediated amyloidosis is a rare, inherited, progressive disease caused by mutations in the transthyretin (TTR) gene. We assessed the safety and efficacy of long-term treatment with patisiran, an RNA interference therapeutic that inhibits TTR production, in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy. Methods: This multicentre, open-label extension (OLE) trial enrolled patients at 43 hospitals or clinical centres in 19 countries as of Sept 24, 2018. Patients were eligible if they had completed the phase 3 APOLLO or phase 2 OLE parent studies and tolerated the study drug. Eligible patients from APOLLO (patisiran and placebo groups) and the phase 2 OLE (patisiran group) studies enrolled in this global OLE trial and received patisiran 0·3 mg/kg by intravenous infusion every 3 weeks with plans to continue to do so for up to 5 years. Efficacy assessments included measures of polyneuropathy (modified Neuropathy Impairment Score +7 [mNIS+7]), quality of life, autonomic symptoms, nutritional status, disability, ambulation status, motor function, and cardiac stress, with analysis by study groups (APOLLO-placebo, APOLLO-patisiran, phase 2 OLE patisiran) based on allocation in the parent trial. The global OLE is ongoing with no new enrolment, and current findings are based on the interim analysis of the patients who had completed 12-month efficacy assessments as of the data cutoff. Safety analyses included all patients who received one or more dose of patisiran up to the data cutoff. This study is registered with ClinicalTrials.gov, NCT02510261. Findings: Between July 13, 2015, and Aug 21, 2017, of 212 eligible patients, 211 were enrolled: 137 patients from the APOLLO-patisiran group, 49 from the APOLLO-placebo group, and 25 from the phase 2 OLE patisiran group. At the data cutoff on Sept 24, 2018, 126 (92%) of 137 patients from the APOLLO-patisiran group, 38 (78%) of 49 from the APOLLO-placebo group, and 25 (100%) of 25 from the phase 2 OLE patisiran group had completed 12-month assessments. At 12 months, improvements in mNIS+7 with patisiran were sustained from parent study baseline with treatment in the global OLE (APOLLO-patisiran mean change -4·0, 95 % CI -7·7 to -0·3; phase 2 OLE patisiran -4·7, -11·9 to 2·4). Mean mNIS+7 score improved from global OLE enrolment in the APOLLO-placebo group (mean change from global OLE enrolment -1·4, 95% CI -6·2 to 3·5). Overall, 204 (97%) of 211 patients reported adverse events, 82 (39%) reported serious adverse events, and there were 23 (11%) deaths. Serious adverse events were more frequent in the APOLLO-placebo group (28 [57%] of 49) than in the APOLLO-patisiran (48 [35%] of 137) or phase 2 OLE patisiran (six [24%] of 25) groups. The most common treatment-related adverse event was mild or moderate infusion-related reactions. The frequency of deaths in the global OLE was higher in the APOLLO-placebo group (13 [27%] of 49), who had a higher disease burden than the APOLLO-patisiran (ten [7%] of 137) and phase 2 OLE patisiran (0 of 25) groups. Interpretation: In this interim 12-month analysis of the ongoing global OLE study, patisiran appeared to maintain efficacy with an acceptable safety profile in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy. Continued long-term follow-up will be important for the overall assessment of safety and efficacy with patisiran.info:eu-repo/semantics/publishedVersio

Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

Background: COVID-19 has been associated with a broad range of thromboembolic, ischemic, and hemorrhagic complications (coagulopathy complications). Most studies have focused on patients with severe disease from high-income countries (HICs). Objectives: The main aims were to compare the frequency of coagulopathy complications in developing countries (low- and middle-income countries [LMICs]) with those in HICs, delineate the frequency across a range of treatment levels, and determine associations with in-hospital mortality. Methods: Adult patients enrolled in an observational, multinational registry, the International Severe Acute Respiratory and Emerging Infections COVID-19 study, between January 1, 2020, and September 15, 2021, met inclusion criteria, including admission to a hospital for laboratory-confirmed, acute COVID-19 and data on complications and survival. The advanced-treatment cohort received care, such as admission to the intensive care unit, mechanical ventilation, or inotropes or vasopressors; the basic-treatment cohort did not receive any of these interventions. Results: The study population included 495,682 patients from 52 countries, with 63% from LMICs and 85% in the basic treatment cohort. The frequency of coagulopathy complications was higher in HICs (0.76%-3.4%) than in LMICs (0.09%-1.22%). Complications were more frequent in the advanced-treatment cohort than in the basic-treatment cohort. Coagulopathy complications were associated with increased in-hospital mortality (odds ratio, 1.58; 95% CI, 1.52-1.64). The increased mortality associated with these complications was higher in LMICs (58.5%) than in HICs (35.4%). After controlling for coagulopathy complications, treatment intensity, and multiple other factors, the mortality was higher among patients in LMICs than among patients in HICs (odds ratio, 1.45; 95% CI, 1.39-1.51). Conclusion: In a large, international registry of patients hospitalized for COVID-19, coagulopathy complications were more frequent in HICs than in LMICs (developing countries). Increased mortality associated with coagulopathy complications was of a greater magnitude among patients in LMICs. Additional research is needed regarding timely diagnosis of and intervention for coagulation derangements associated with COVID-19, particularly for limited-resource settings

Liver injury in hospitalized patients with COVID-19: An International observational cohort study

Background: Using a large dataset, we evaluated prevalence and severity of alterations in liver enzymes in COVID-19 and association with patient-centred outcomes.MethodsWe included hospitalized patients with confirmed or suspected SARS-CoV-2 infection from the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) database. Key exposure was baseline liver enzymes (AST, ALT, bilirubin). Patients were assigned Liver Injury Classification score based on 3 components of enzymes at admission: Normal; Stage I) Liver injury: any component between 1-3x upper limit of normal (ULN); Stage II) Severe liver injury: any component & GE;3x ULN. Outcomes were hospital mortality, utilization of selected resources, complications, and durations of hospital and ICU stay. Analyses used logistic regression with associations expressed as adjusted odds ratios (OR) with 95% confidence intervals (CI).ResultsOf 17,531 included patients, 46.2% (8099) and 8.2% (1430) of patients had stage 1 and 2 liver injury respectively. Compared to normal, stages 1 and 2 were associated with higher odds of mortality (OR 1.53 [1.37-1.71]; OR 2.50 [2.10-2.96]), ICU admission (OR 1.63 [1.48-1.79]; OR 1.90 [1.62-2.23]), and invasive mechanical ventilation (OR 1.43 [1.27-1.70]; OR 1.95 (1.55-2.45). Stages 1 and 2 were also associated with higher odds of developing sepsis (OR 1.38 [1.27-1.50]; OR 1.46 [1.25-1.70]), acute kidney injury (OR 1.13 [1.00-1.27]; OR 1.59 [1.32-1.91]), and acute respiratory distress syndrome (OR 1.38 [1.22-1.55]; OR 1.80 [1.49-2.17]).ConclusionsLiver enzyme abnormalities are common among COVID-19 patients and associated with worse outcomes